The FDA issued a Class I recall on more than 4,100 TigerPaw II implantable left atrial appendage occlusion devices based on reports of possible tissue tearing and bleeding.

The cardiology community has heeded the call to protect patients from radiation exposure in the cath lab. Now it is time to focus on the operators and staff.

No more sour grapes from white wine drinkers who bemoan that only reds get accolades for being heart-healthy. An article in the magazine Wine Spectator reviews the health benefits of white wines, citing mouse studies and other sources.

An everolimus-eluting stent with a bioresorbable coating held its own clinically against a durable polymer drug-eluting stent in the pivotal EVOLVE II trial, findings that may be used to determine regulatory approval of the bioresorbable device.

Patients with acute ischemic stroke had a reduction in the severity of disability and an increase in functional independence after they received mechanical thrombectomy with the Solitaire stent retriever, according to a multicenter, prospective, randomized trial.

Medtronic plc today announced the start of a new feasibility study to evaluate the safety and effectiveness of the Valiant Mona LSA branch thoracic stent graft system, an investigational medical device designed to enable a completely endovascular solution for aortic aneurysms encroaching on the left subclavian artery (LSA).

Patients with type 1 diabetes had double the risk of death after undergoing CABG compared with a group that did not have diabetes, according to an observational, nationwide population-based cohort study.

The Harvard Clinical Research Institute (HCRI) has been selected by the American College of Cardiology to be the Data Analytic Center for the atrial fibrillation (AF) platform of the ACC PINNACLE Registry.